Collaboration between Bhami Research and Zumutor Inc
Bhami Resarch and Zumutor aim to work in collaboration for a unique portfolio of crystallization enabled Mabs which will be supported by Zumutor’s analytical tool kit of niche services.
This collaboration will also enable a joint offering for Zumutor’s Biosimilars and ADCC improved antibodies using Bhami’s crystallization technologies.
About Bhami Research and Zumutor Inc.
Bhami Research :
BRL is a Mangalore based company that works in the area of protein purification, analytical characterization and formulation. This company has a proprietary novel crystallization technology used for the purification of proteins especially monoclonal antibodies. The expertise in protein crystallization has been demonstrated through efficacy data in Trastuzumab crystallization, and this purification tool has in turn reduced downstream footprint and thus achieved higher process economics.
Zumutor Biologics Inc is a pre-clinical stage biologics discovery and development company, headquartered in Woburn, MA with Research & Development facility in Bangalore, India.
With combined team experience of over 100 years in global institutes and companies, Zumutor’s holistic expertise encompasses state-of-the-art technologies and development models.
At Zumutor, we combine two proprietary technology platforms to create new glyco-engineered monoclonal antibodies which identify unique target epitopes.
Our goal is to develop new drugs with breakaway potential in Oncology and Autoimmune disorders. We are committed to creating portfolio value for partners, both regional and across the world with biotherapeutics that meet international quality standards. For more information, please visit zumutor.com